v3 Template
S

Sarepta Therapeutics Inc.

Biotechnology / Biopharmaceutical Los Angeles, CA ~580 employees
Founded
--
Employees (Est.)
~580
29 leaders known
Total Funding
$891.4M
Funding Rounds
2
Last Funding
2025-12-11

About Sarepta Therapeutics Inc.

Sarepta Therapeutics is a global biotechnology company focused on engineering precision genetic medicine to address rare diseases. Their mission is to transform genetic understanding into effective treatments, shorten drug development timelines, and build significant gene therapy manufacturing capacity while rethinking access and reimbursement models for innovative treatments.

Products & Services

FDA-Approved Treatments:Sarepta offers FDA-approved treatments for rare diseases, with further details available on their product page.
Gene Therapy, RNA Technologies, and Gene Editing Platforms:Sarepta develops solutions using advanced platforms including gene therapy, RNA technologies, and gene editing, aimed at treating rare diseases.
Pipeline and Clinical Trials:Sarepta has a pipeline of potential treatments and ongoing clinical trials focused on rare diseases.

Specialties

Precision Genetic Medicine Gene Therapy RNA Technologies Gene Editing Rare Disease Treatment Manufacturing of Gene Therapies

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Convertible Senior Notes Exchange
T: -
FT: Convertible Senior Notes Exchange
A: 291400000
MR: -
FA: approximately $291.4 million
FAN: 291400000
D: 2025-12-11
FD: 2025-12-11
-
2 RT: Debt
T: -
FT: Debt
A: 600000000
MR: -
FA: $600 million
FAN: 600000000
D: 2025-02-14
FD: 2025-02-14
9 investors
Convertible Senior Notes Exchange Latest
2025-12-11
$291.4M
Debt 2025-02-14
$600.0M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

W

Wendy Erler

Senior Vice President, Patient Affairs

N

Nicole LaMarca

Senior Director, Patient Affairs

R

Rachita Chaudhury-Floros

Associate Director, Patient Affairs

M

Monique Dabbous

Associate Director, Patient Affairs

K

Katherine Sinars

Senior Specialist, Patient Affairs

R

Rachael Titus

Senior Specialist, Patient Affairs

View 26 more team members with Pro

Unlock Full Team Directory

Recent News

Sarepta Therapeutics Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology / Biopharmaceutical
Company Size
~580 employees (est.)
Locations
Los Angeles, CA
United States
Radnor, PA, United States +5 more

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro